Analyst Ratings for AcelRx Pharmaceuticals (ACRX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/2/2023 | Alliance Global Partners | James Molloy | New Coverage | Buy (N/A) |
4.25 (N/A) |
0.58 (0.86) |
48.28% | Details |
| 8/18/2023 | H.C. Wainwright » Updated 9/25/2023 |
Ed Arce | Upgrade | Buy (Neutral) |
5.00 (8.00) |
0.84 (0.86) |
2.38% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


